Literature DB >> 33583071

Use of psychiatric medication by college students: A decade of data.

Marcia R Morris1, Carolin C Hoeflich2, Sara Nutley2, Vicki L Ellingrod3, Michelle B Riba4, Catherine W Striley2.   

Abstract

OBJECTIVES: Given the rising prevalence of psychiatric symptomatology among college students, this analysis aims to identify temporal trends in psychiatric medication usage.
METHODS: This analysis used data from the Healthy Minds Study Survey administered between 2007 and 2019, yielding a sample of 320,817 university students. Survey data were examined via descriptive analyses.
RESULTS: Over the last decade from 2007 to 2018-2019, there was an increase in use of nearly all classes of psychiatric medications, with reported antidepressant medication (selective serotonin reuptake inhibitors [SSRIs], serotonin-norepinephrine reuptake inhibitors [SNRIs], etc.) use increasing from 8.0% to 15.3%, anti-anxiety medication (benzodiazepines, buspirone, etc.) from 3.0% to 7.6%, psychostimulants from 2.1% to 6.3%, antipsychotics from 0.38% to 0.92%, and mood stabilizers from 0.8% to 2.0% (all p < 0.0001), respectively. In addition, the use of more than one category of medication at a time has increased, from 28.2% in 2007 to 40.8% in 2018-2019 (p < 0.0001). The proportion of students who received their most recent prescription for psychiatric medication from primary care providers has risen from 49.1% in 2007 to 58.8% in 2018-2019 (p < 0.0001), while the proportion receiving these prescriptions from psychiatric providers did not increase significantly and stands at 36.1% in 2018-2019. The percentage of students taking psychiatric medication without a prescription varied from year to year, starting at 11.9% in 2007 and ending at 7.7% in 2018-2019 (p < 0.0001). The proportion of students who discussed their use of psychiatric medication with their doctor or other health professional three or more times in the previous year has increased from 39.2% in 2007 to 49.5% in 2018-2019 (p < 0.0001).
CONCLUSIONS: The proportion of college students who have taken psychiatric medications of all categories has risen in the last decade; these students are increasingly likely to be on more than one kind of psychiatric medication and be treated by healthcare providers at a greater frequency. Despite the growing complexity of student treatment, the proportion of students receiving psychiatric medication management by psychiatric providers has not changed, while the proportion receiving services in primary care settings has increased.
© 2021 Pharmacotherapy Publications, Inc.

Entities:  

Keywords:  antidepressants; benzodiazepines; college mental health; polypharmacy; psychiatric medication

Mesh:

Substances:

Year:  2021        PMID: 33583071     DOI: 10.1002/phar.2513

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  3 in total

1.  Psychotropic Drugs and Adverse Kidney Effects: A Systematic Review of the Past Decade of Research.

Authors:  Joseph Junior Damba; Katie Bodenstein; Paola Lavin; Jessica Drury; Harmehr Sekhon; Christel Renoux; Emilie Trinh; Soham Rej; Kyle T Greenway
Journal:  CNS Drugs       Date:  2022-09-26       Impact factor: 6.497

2.  Mental Health of PhD Students at Polish Universities-Before the COVID-19 Outbreak.

Authors:  Mateusz Kowalczyk; Michał Seweryn Karbownik; Edward Kowalczyk; Monika Sienkiewicz; Monika Talarowska
Journal:  Int J Environ Res Public Health       Date:  2021-11-17       Impact factor: 3.390

3.  E-cigarettes and non-suicidal self-injury: Prevalence of risk behavior and variation by substance inhaled.

Authors:  Catherine W Striley; Sara K Nutley; Carolin C Hoeflich
Journal:  Front Psychiatry       Date:  2022-09-06       Impact factor: 5.435

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.